GEN Exclusives

More »

GEN News Highlights

More »
Oct 18, 2006

Malaria Discovery Collaboration Agreement Expanded

  • Medicines for Malaria Venture (MMV), Genzyme, and the Broad Institute of MIT and Harvard expanded their collaboration to discover and advance new therapeutic candidates for malaria. The alliance will build on work begun earlier this year to extend a drug discovery program focused on identifying compounds that offer a completely new approach to treating malaria.

    In addition to co-funding and co-managing this effort with Genzyme and the Broad Institute, MMV will also work with the two partners to secure additional resources to scale-up the program further. Currently, there are four early discovery projects in this portfolio, the collaborators inform. All intellectual property developed under this collaboration will be made available to MMV on a royalty-free basis for use in developing and distributing new drugs for the treatment of malaria.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Children and Antipsychotic Drugs

Do you think children and adolescents with behavioral problems are overmedicated?